In obese patients, 5 percent weight loss has significant health benefits

February 22, 2016

For patients with obesity trying to lose weight, the greatest health benefits come from losing just 5 percent of their body weight, according to a new study at Washington University School of Medicine in St. Louis.

Researchers found that the relatively small weight loss markedly lowered patients' risk for diabetes and cardiovascular disease and improved metabolic function in liver, fat and muscle tissue.

The study is published online Feb. 22 in the journal Cell Metabolism.

"Our findings demonstrate that you get the biggest bang for your buck with 5 percent weight loss," said principal investigator Samuel Klein, MD, director of Washington University's Center for Human Nutrition. "The current guidelines for treating obesity recommend a 5 to 10 percent weight loss, but losing 5 percent of your body weight is much easier than losing 10 percent. So it may make sense for patients to aim at the easier target."

Klein, the William H. Danforth Professor of Medicine and Nutritional Science and chief of the Division of Geriatrics and Nutritional Science, randomly assigned 40 obese individuals -- none of whom had diabetes -- to either maintain their body weight or go on a diet to lose 5, 10 or 15 percent of body weight. The researchers looked at whole body, organ system and cellular responses before and after the weight loss.

While other randomized clinical trials have evaluated the effects of varying weight loss in people with obesity, this is thought to be the first time a trial has separated weight loss outcomes in people who achieved a 5 percent weight loss from those who achieved a 10 percent or greater weight loss.

Among the 19 study volunteers who lost 5 percent of their body weight, the function of insulin-secreting beta cells improved, as did insulin sensitivity in fat tissue, liver and skeletal muscle tissue. A 5 percent weight loss also was associated with decreases in total body fat and with much less fat in the liver.

Meanwhile, nine of those study patients continued to lose weight, eventually reaching 15 percent weight loss. They experienced further improvements in beta cell function and insulin sensitivity in muscle tissue, but neither insulin sensitivity in the liver nor adipose (fat) tissue continued to improve with the greater weight loss.

"Continued weight loss is good, but not all organ systems respond the same way," Klein said. "Muscle tissue responds much more to continued weight loss, but liver and adipose tissue have pretty much achieved their maximum benefit at 5 percent weight loss."

Interestingly, markers of inflammation, which are elevated in people with obesity, didn't change much when study subjects lost a moderate amount of weight. Although scientists hypothesize that increased inflammation in fat tissue contributes to metabolic problems such as insulin resistance, this study found that metabolic function could improve while markers of inflammation remain unchanged.

That element of the research will require further study. Klein also wants to expand the study to people who have diabetes.

"We don't know whether people with diabetes will have the same response to this type of progressive weight loss, so it will be important in the future to repeat this type of study in people who have type 2 diabetes," he said.

In the meantime, Klein said people with obesity can benefit significantly from losing even a little bit of weight.

"If you weigh 200 pounds, you will be doing yourself a favor if you can lose 10 pounds and keep it off," he said. "You don't have to lose 50 pounds to get important health benefits."
-end-
Funding for this research comes from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), grant numbers DK 37948, DK 104995, DK 56341, DK 20579, RR 024992 and TR 000450; the Pershing Square Foundation and the Longer Life Foundation.

Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, de las Fuentes L, He S, Okunade AL, Patterson BW Klein S. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metabolism, published online Feb. 22, 2016. http://dx.doi.org/10.1016/j.cmet.2016.02.005

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Washington University School of Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.